Article info
PDFClinical pharmacy
CP-129 Use of macitentan on pulmonary arterial hypertension as an alternative to other endotelin receptor antagonists
Citation
CP-129 Use of macitentan on pulmonary arterial hypertension as an alternative to other endotelin receptor antagonists
Publication history
- First published February 25, 2017.
Online issue publication
April 07, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2017, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions